Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEOGEN CORPNEOG · Entity 4338 | Director | October 06, 2016 | October 11, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEOGEN CORP
Report date October 06, 2016 · Filed October 11, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.14 · Expires 2026-10-06 | Direct | 25,500 |
Reported balance
After 2016-10-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2016-10-06 · Grant · Acquired 3,000 · Balance 25,500 F1: These NQ options were granted 10/6/2016, vest in three equal annual installments on the first three anniversary dates of the grant, and have ten year lives |
Filing footnotes · ownership attribution and instrument terms
F1: These NQ options were granted 10/6/2016, vest in three equal annual installments on the first three anniversary dates of the grant, and have ten year lives
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 06, 2016 Filed Oct 11, 2016 15:30 UTC | NEOGEN CORP NEOG · Entity 4338 | GrantCommon Stock (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $55.14 | $0.00 |
DisclosureSEC source: 0000711377-16-000093 · primary_doc.xml · derivative · entry 1 FISCHER A. CHARLES · CIK 0001380814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,500 Underlying: Common Stock · 3,000 shares Expires 2026-10-06 F1 · derivative.exercise_date: These NQ options were granted 10/6/2016, vest in three equal annual installments on the first three anniversary dates of the grant, and have ten year lives Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.